Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02915523
Title Phase 1b/2 Study of Avelumab With or Without Entinostat in Patients With Advanced Epithelial Ovarian Cancer
Recruitment Unknown status
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Syndax Pharmaceuticals

peritoneum cancer

ovary epithelial cancer

fallopian tube cancer



Avelumab + Entinostat

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.